---
figid: PMC3682694__cmo-7-2013-103f1
figtitle: Roles of molecules explained in this review in signal transduction
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3682694
filename: cmo-7-2013-103f1.jpg
figlink: /pmc/articles/PMC3682694/figure/f1-cmo-7-2013-103/
number: F1
caption: 'Roles of molecules explained in this review in signal transduction. The
  PI3K-Akt pathway is a major survival pathway activated in cancer. The PTEN tumor
  suppressor is the major brake of the pathway and a common target for inactivation
  in somatic cancers. In various human cancers, PTEN is frequently found to be mutated,
  deleted, or epigenetically silenced. This review highlights the networking of PTEN
  with other inhibitors of the pathway, relevant to cancer progression. PTEN constitutes
  the main node of the inhibitory network, and a series of convergences at different
  levels in the PI3K-Akt pathway, starting from those with growth factor receptors,
  are described. PTEN exerts enzymatic activity as a phosphatidylinositol-3,4,5-trisphosphate
  (PIP(3)) phosphatase; thus, opposing the activity of PI3K, the concerted actions
  to increase the availability of PIP(3) in cancer cells, relying either on other
  phosphoinositide enzymes or on the intrinsic regulation of PTEN activity by other
  molecules are discussed. Particularly, the synergy between PTEN and the circle of
  its direct interacting proteins will be brought forth in an attempt to understand
  both the activation of the PI3K-Akt pathway and the connections with other parallel
  oncogenic pathways. PI3K is a major signaling hub downstream of HER2 and other receptor
  tyrosine kinases. PI3K activates AKT, serum/glucocorticoid regulated kinase, phosphoinositide-dependent
  kinase 1 (PDK1), mammalian target of rapamycin (mTOR), and several other molecules
  involved in cell cycle progression and survival. Recent new findings have demonstrated
  that PTEN also plays a critical role in DNA damage repair and DNA damage response.
  Phosphorylation of CHK2 is triggered by DNA damage induced by ionizing radiation
  (IR) or hydroxyurea (HU). Functional ATM protein is required for CHK2 phosphorylation
  following IR, but not HU treatment.Notes: It has been reported that PTEN dosage
  is essential for neurofibroma development and malignant transformation. Loss of
  Pten in combination with overexpression of the K-ras oncogene is an important step
  in malignant peripheral nerve sheath tumor development. pVHL directly associates
  with and stabilizes p53 by suppressing Mdm2-mediated ubiquitination and nuclear
  export of p53. Moreover, upon genotoxic stress, pVHL causes acetylation of p53,
  which ultimately leads to increased p53 transcriptional activity and p53-mediated
  cell cycle arrest and apoptosis. Understanding the interplay between the modulators
  of the PI3K-Akt pathway in cancer will lead to the design of novel therapeutic approaches
  with increased efficacy in the clinic.Abbreviations: SET, suppressor of variegation,
  enhancer of zeste, and trithorax; PPA2, protein phosphatase A2; FOXO, forkhead box
  O; Tsc1, tuberous sclerosis 1; RheB, ras homologue enriched in brain; mTOR, mammalian
  target of rapamycin.'
papertitle: Recent Progress in Mouse Models for Tumor Suppressor Genes and its Implications
  in Human Cancer.
reftext: Kazushi Inoue, et al. Clin Med Insights Oncol. 2013;7:103-122.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9697333
figid_alias: PMC3682694__F1
figtype: Figure
redirect_from: /figures/PMC3682694__F1
ndex: 6f7058ce-deb2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3682694__cmo-7-2013-103f1.html
  '@type': Dataset
  description: 'Roles of molecules explained in this review in signal transduction.
    The PI3K-Akt pathway is a major survival pathway activated in cancer. The PTEN
    tumor suppressor is the major brake of the pathway and a common target for inactivation
    in somatic cancers. In various human cancers, PTEN is frequently found to be mutated,
    deleted, or epigenetically silenced. This review highlights the networking of
    PTEN with other inhibitors of the pathway, relevant to cancer progression. PTEN
    constitutes the main node of the inhibitory network, and a series of convergences
    at different levels in the PI3K-Akt pathway, starting from those with growth factor
    receptors, are described. PTEN exerts enzymatic activity as a phosphatidylinositol-3,4,5-trisphosphate
    (PIP(3)) phosphatase; thus, opposing the activity of PI3K, the concerted actions
    to increase the availability of PIP(3) in cancer cells, relying either on other
    phosphoinositide enzymes or on the intrinsic regulation of PTEN activity by other
    molecules are discussed. Particularly, the synergy between PTEN and the circle
    of its direct interacting proteins will be brought forth in an attempt to understand
    both the activation of the PI3K-Akt pathway and the connections with other parallel
    oncogenic pathways. PI3K is a major signaling hub downstream of HER2 and other
    receptor tyrosine kinases. PI3K activates AKT, serum/glucocorticoid regulated
    kinase, phosphoinositide-dependent kinase 1 (PDK1), mammalian target of rapamycin
    (mTOR), and several other molecules involved in cell cycle progression and survival.
    Recent new findings have demonstrated that PTEN also plays a critical role in
    DNA damage repair and DNA damage response. Phosphorylation of CHK2 is triggered
    by DNA damage induced by ionizing radiation (IR) or hydroxyurea (HU). Functional
    ATM protein is required for CHK2 phosphorylation following IR, but not HU treatment.Notes:
    It has been reported that PTEN dosage is essential for neurofibroma development
    and malignant transformation. Loss of Pten in combination with overexpression
    of the K-ras oncogene is an important step in malignant peripheral nerve sheath
    tumor development. pVHL directly associates with and stabilizes p53 by suppressing
    Mdm2-mediated ubiquitination and nuclear export of p53. Moreover, upon genotoxic
    stress, pVHL causes acetylation of p53, which ultimately leads to increased p53
    transcriptional activity and p53-mediated cell cycle arrest and apoptosis. Understanding
    the interplay between the modulators of the PI3K-Akt pathway in cancer will lead
    to the design of novel therapeutic approaches with increased efficacy in the clinic.Abbreviations:
    SET, suppressor of variegation, enhancer of zeste, and trithorax; PPA2, protein
    phosphatase A2; FOXO, forkhead box O; Tsc1, tuberous sclerosis 1; RheB, ras homologue
    enriched in brain; mTOR, mammalian target of rapamycin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SERPINA4
  - MTG1
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - ATM
  - PRKDC
  - PKD1
  - NF1
  - SET
  - PPA2
  - AKT1
  - AKT2
  - AKT3
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - CHEK2
  - GSK3B
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - VHL
  - TP53
  - TP63
  - TP73
  - TSC2
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - MYC
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CDC25C
  - RASGRF1
  - CDC25A
  - CDC25B
  - CTNNB1
  - APC
  - PROC
  - MTOR
  - Cancer
  - Lung cancer
---
